Results of these studies will enable a deeper understanding of leptin physiology and possible therapeutic applications as well as prevention of obesity and metabolic disease associated with leptin and leptin receptor heterozygosity or partial leptin deficiency. This evidence concerns the gene LEPR and obesity due to melanocortin 4 receptor deficiency.